These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8210609)

  • 1. Cessation of long-term naltrexone therapy and self-injury: a case study.
    Crews WD; Bonaventura S; Rowe FB; Bonsie D
    Res Dev Disabil; 1993; 14(4):331-40. PubMed ID: 8210609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities.
    Rana F; Gormez A; Varghese S
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009084. PubMed ID: 23633366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cessation of long-term naltrexone administration: longitudinal follow-ups.
    Crews WD; Rhodes RD; Bonaventura SH; Rowe FB; Goering AM
    Res Dev Disabil; 1999; 20(1):23-30. PubMed ID: 9987808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.
    Willemsen-Swinkels SH; Buitelaar JK; Nijhof GJ; van England H
    Arch Gen Psychiatry; 1995 Sep; 52(9):766-73. PubMed ID: 7654128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report of naltrexone treatment of self-injury and social withdrawal in autism.
    Walters AS; Barrett RP; Feinstein C; Mercurio A; Hole WT
    J Autism Dev Disord; 1990 Jun; 20(2):169-76. PubMed ID: 2189867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of naltrexone on self-injurious behavior.
    Sandman CA; Hetrick W; Taylor DV; Marion SD; Touchette P; Barron JL; Martinezzi V; Steinberg RM; Crinella FM
    Am J Ment Retard; 2000 Mar; 105(2):103-17. PubMed ID: 10755174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone and self-injurious behavior: a retrospective population study.
    Casner JA; Weinheimer B; Gualtieri CT
    J Clin Psychopharmacol; 1996 Oct; 16(5):389-94. PubMed ID: 8889912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone treatment for a 3-year-old boy with self-injurious behavior.
    White T; Schultz SK
    Am J Psychiatry; 2000 Oct; 157(10):1574-82. PubMed ID: 11007709
    [No Abstract]   [Full Text] [Related]  

  • 9. Opiate antagonists for recurrent self-injurious behavior in three mentally retarded adults.
    Buzan RD; Dubovsky SL; Treadway JT; Thomas M
    Psychiatr Serv; 1995 May; 46(5):511-2. PubMed ID: 7627682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of naltrexone upon self-injurious behavior, learning and activity: a case study.
    Taylor DV; Hetrick WP; Neri CL; Touchette P; Barron JL; Sandman CA
    Pharmacol Biochem Behav; 1991 Sep; 40(1):79-82. PubMed ID: 1780350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone attenuates self-injurious behavior in mentally retarded subjects.
    Kars H; Broekema W; Glaudemans-van Gelderen I; Verhoeven WM; van Ree JM
    Biol Psychiatry; 1990 Apr; 27(7):741-6. PubMed ID: 2158355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone as a treatment of self-injurious behavior--a case report.
    Griengl H; Sendera A; Dantendorfer K
    Acta Psychiatr Scand; 2001 Mar; 103(3):234-6. PubMed ID: 11240582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential analysis of the effects of naltrexone on the environmental mediation of self-injurious behavior.
    Symons FJ; Tapp J; Wulfsberg A; Sutton KA; Heeth WL; Bodfish JW
    Exp Clin Psychopharmacol; 2001 Aug; 9(3):269-76. PubMed ID: 11534537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
    Roth AS; Ostroff RB; Hoffman RE
    J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case study: paradoxical response to naltrexone treatment of self-injurious behavior.
    Benjamin S; Seek A; Tresise L; Price E; Gagnon M
    J Am Acad Child Adolesc Psychiatry; 1995 Feb; 34(2):238-42. PubMed ID: 7896657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities: Abridged republication of a Cochrane systematic review.
    Gormez A; Rana F; Varghese S
    J Psychopharmacol; 2014 Jul; 28(7):624-32. PubMed ID: 24785762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid antagonist effects on self-injury in adults with mental retardation: response form and location as determinants of medication effects.
    Thompson T; Hackenberg T; Cerutti D; Baker D; Axtell S
    Am J Ment Retard; 1994 Jul; 99(1):85-102. PubMed ID: 7946257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone treatment of dementia with severe self-injurious behaviors: a single case study.
    Vance HB; Kauffmann C; Pumariega AJ; Del Mundo A
    Psychiatry; 2000; 63(3):288-99. PubMed ID: 11125673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone in treatment of self injurious behavior: a clinical study.
    Szymanski L; Kedesdy J; Sulkes S; Cutler A; Stevens-Our P
    Res Dev Disabil; 1987; 8(2):179-90. PubMed ID: 3671810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress and self-injurious behavior; hormonal and serotonergic parameters in mentally retarded subjects.
    Verhoeven WM; Tuinier S; van den Berg YW; Coppus AM; Fekkes D; Pepplinkhuizen L; Thijssen JH
    Pharmacopsychiatry; 1999 Jan; 32(1):13-20. PubMed ID: 10071178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.